Showing results (1781-1790 of 2,138) with videos related to

Sort By:
Pageof 214
Urology|November 17, 2019
Comparison of Open and Robot Assisted Radical Nephrectomy With Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic ExperienceKyle M Rose, Anojan K Navaratnam, Kassem S Faraj, et al.
American Journal of Ophthalmology|November 5, 2003
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucomaWallace L M Alward, Young H Kwon, Kazuhide Kawase, et al.
British Journal of Haematology|July 17, 2019
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignanciesEllen Weisberg, Chengcheng Meng, Abigail E Case, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinRobin L Carhart-Harris, David Erritzoe, Tim Williams, et al.
The Journal of Infectious Diseases|October 3, 2017
A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral DefenseEmma Svedin, Renata Utorova, Michael H Hühn, et al.
Nature Medicine|December 13, 2006
Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformationTing Xi Liu, Michael W Becker, Jaroslav Jelinek, et al.
The British Journal of Ophthalmology|September 17, 2024
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2Alec L Amram, S Scott Whitmore, Cheryl Wang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Leukemia|February 24, 2015
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cellsHaymanti Bhanot, Mamatha M Reddy, Atsushi Nonami, et al.
Pageof 214